CG
HOOK

Cutler Group’s HOOKIPA Pharma HOOK Stock Holding History

Cutler Group’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-370
Closed -$4K – 4720
2022
Q3 		$4K Buy
370
+130
+54% +$2K ﹤0.01% 3785
2022
Q2 		$3K Sell
240
-1,204
-83% -$19.9K ﹤0.01% 4051
2022
Q1 		$32K Buy
+1,444
New +$25.9K ﹤0.01% 2634

Other funds holding HOOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cutler Group's HOOK Position: Q4 2022 in Review

Cutler Group sold out of HOOKIPA Pharma (HOOK) in Q4 2022, closing a stake of 370 shares — an estimated $4K sold.

Cutler Group first reported a position in HOOK in Q1 2022 and held it in 3 quarters. The position peaked at $32K in Q1 2022. 55 funds tracked by Wall St. Rank hold HOOK as of Q4 2022.

  • Cutler Group reported no remaining HOOKIPA Pharma position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 370 HOOKIPA Pharma shares in Q4 2022, an estimated $4K.
  • Cutler Group first reported a position in HOOKIPA Pharma in Q1 2022 and held it in 3 quarters.
  • Cutler Group's HOOKIPA Pharma position peaked at $32K in Q1 2022.
  • 55 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.